Through the alliance, Cornell has joined the Consortium for Sequencing the Food Supply Chain, an initiative launched by IBM and Mars in early 2015.
Revenue growth was driven by a 26 percent increase in the number of pathogen detection tests sold. The total number of placed Atlas instruments ticked up to 54.
The company said it will use the proceeds to support the development of a prototype pathogen detection platform.
Hygiena will sell DuPont Diagnostics products through its Qualicon Diagnostics unit.
The company said its acquisition of DuPont Diagnostics will allow it to provide a broader array of food safety diagnostics services to its customers.
The food safety firm is using NGS testing and data analytics to create actionable information for retailers and manufacturers.
The firms also renewed distribution agreements for DuPont's BAX System Q7 food safety testing platform in Canada, Australia and New Zealand.
The revenue spike was due to an increase in the number of Atlas molecular testing platforms placed with commercial customers.
Under the terms of the agreements, Qiagen will make CosmosID's platform available as a plug in, and Trigent will supply Qiagen's software to the FDA.
At the end of the quarter, the company had 39 of its Atlas molecular testing instruments placed with customers under commercial agreements compared to 36 in Q3 2014.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.